SCHEMBL8949077

SCHEMBL8949077

CCOc1nc(-c2ccc(C(=N)N)cc2)ncc1C(=O)N(C)[C@H]1CC[C@H](C(=O)O)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 1/20 0.39
SYK P43405 2/20 0.36
ALDH1A1 P00352 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
CYP1A2 P05177 2/20 0.36
POLB P06746 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GSK3B P49841 2/20 0.35
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
MAPT P10636 2/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
RAB9A P51151 1/20 0.35
TMPRSS15 P98073 1/20 0.35
DYRK1A Q13627 1/20 0.34
PRSS1 P07477 1/20 0.34
PRSS2 P07478 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9571663 1.00 HTR2B (0.39) HTR2BSYKALDH1A1SMN1; SMN2CYP1A2
SCHEMBL8949043 0.91 HSD11B1 (0.38) HTR2BSYKALDH1A1SMN1; SMN2CYP1A2
SCHEMBL8949047 0.91 HSD11B1 (0.38) HTR2BSYKALDH1A1SMN1; SMN2CYP1A2
SCHEMBL8949414 0.81 ITGB3 (0.39) SYKPOLBITGB3ITGA2BTMPRSS15
SCHEMBL8949416 0.81 ITGB3 (0.39) SYKPOLBITGB3ITGA2BTMPRSS15
SCHEMBL8887118 0.77 USP30 (0.44) ITGB3ITGA2BPRSS1PRSS2PRSS3
SCHEMBL9094547 0.77 USP30 (0.44) ITGB3ITGA2BPRSS1PRSS2PRSS3
SCHEMBL9185327 0.74 ITGB3 (0.38) ALDH1A1CYP1A2CYP2C9ITGB3ITGA2B
SCHEMBL8886191 0.73 PDE4A (0.41) ITGB3ITGA2BPRSS1PRSS2PRSS3
SCHEMBL8949165 0.73 GSK3B (0.47) SYKGSK3BITGB3ITGA2BPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5563268-A FOR PREVENTING CELL AGGLOMERATION, TREATING THROMBOSIS, ARTERIOSCLEROSIS, BRAIN, LUNG OR CARDIOVASCULAR DISORDERS DR. KARL THOMAE GMBH (DE) 1996-10-08 US disclosed
US-5418233-A FOR INHIBITING CELL AGGREGATION KARL THOMAE GMBH (DE) 1995-05-23 US disclosed
EP-0537696-A1 Heterobiaryl derivatives, medicines containing those compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1993-04-21 EP disclosed